TIS1O/PGS2 ATF/CRE element. Expression of a dominant-negative ras gene also blocks TIS10/PGS2 induction by v-src. Our data suggest that Ras mediates pp60V' activation of an ATF transcription factor, leading to induced TIS10/PGS2 expression via the ATF/CRE element of the TIS10/PGS2 promoter. This is the first description of v-src activation of gene expression via an ATF/CRE element.
Prostaglandin synthase (PGS) is the key enzyme in the synthesis of the prostanoids (prostaglandins, prostacyclins, and thromboxanes) from arachidonic acid (12) . PGS converts arachidonic acid released from membrane stores to PGH2, the precursor to all prostanoids. Prostanoids modulate many normal physiological processes, including cell division, the immune response, reproduction, and differentiation. Elevated prostanoids are also associated with pathophysiological states such as pain, fever, acute and chronic inflammation, atherosclerosis, and cancer. PGS1 (EC 1.4.99.1) has been well characterized biochemically, pharmacologically, and structurally (55) .
We identified in Swiss 3T3 cells a mitogen-induced primary response gene, TIS10 (tetradecanoyl phorbol acetate-induced sequence 10 [35] ) that encodes a second prostaglandin synthase (13, 29) . Other laboratories have also identified PGS2 as a growth factor-inducible gene in murine fibroblasts (39, 47) . TIS10/PGS2 induction by appropriate ligands has subsequently been demonstrated in endothelial cells (21) , epithelial cells (22) , monocytes and macrophages (58, 33) , ovarian granulosa cells (51) , osteoblasts (42) , and neurons (62) . The TIS10/PGS2 gene is also inducible in 3T3 cells by v-src (44, 39) . Oncogenic transformation by retroviruses often results in the activation of genes whose transcription is induced in response to mitogens. Xie et al. (61) identified one of the cDNAs for a message induced in chicken embryo fibroblasts by activation of a temperature-sensitive v-src oncogene as an avian PGS.
pp60v-src, the product of the Rous sarcoma virus v-src oncogene, was the first oncogenic protein whose biological * activity, a protein tyrosine kinase, was identified (8) . pp60Vsrc expression is sufficient to initiate and maintain oncogenic transformation (24) . However, the mechanism by which pp60v`s? transforms cells is still largely unknown. Several approaches, including identification of pp60V`S substrates, cloning of cDNAs for messages induced by pp60`vsfl expression, and identification of cis-responsive elements transcriptionally activated by pp6OV, have been taken to identify this mechanism. Gene expression can be induced by pp60vS`through different cis-acting regulatory elements, including AP-1 (5, 19, 48) , the serum response element (43) , the TATA box (2) , and a unique src-responsive element (10) . Because (i) prostanoids are involved in so many normal and pathophysiological responses and (ii) pp6ovsrC is a potent oncogenic protein, the transcriptional regulation of the TIS10/ PGS2 gene by pp6Ovsrc is an important issue. We now report that the ATF/CRE element in the TIS10/PGS2 promoter (13) is essential for induction of TIS10/PGS2 by pp6OvsrC. We also show that v-src induction occurs via a Ras-mediated signal transduction pathway.
MATERIALS AND METHODS
Cell culture. NIH 3T3 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% newborn calf serum. UPlAl cells, a BALB/c 3T3 cell line transfected with a temperature-sensitive v-src gene (37) Electrophoretic mobility gel shift assays. Gel shift assays were carried out essentially as described by Peterson et al. (41) . Oligonucleotide G553 (5'-TCACCACTACGTCACGTGGAG TCCGCT-3') from nucleotide -65 to -39 of the TIS10/PGS2 gene was end labeled with [32P]ATP. The complementary oligonucleotide was annealed, and the resulting doublestranded DNA was purified. Each 20-pu binding reaction mixture contained 40,000 cpm of probe, 6 p,g of nuclear extract, and 6 ,ug of poly(dI-dC) (Pharmacia). Competitors ( Fig. 1) were added to the binding mixture containing poly(dIdC) and nuclear extract 10 min before addition of the probe; incubation was continued for 15 min. For the supershift experiment, anti-CREB antibody was added to the poly(dI-dC) and nuclear extract 15 min before addition of the probe. Five percent nondenaturing acrylamide gel electrophoresis was performed in the cold at 20 mA for 2 to 3 h. Dried gels were exposed to X-ray film.
Methylation interference experiments. A 108-bp probe between nucleotides -28 and -135 of the TIS10/PGS2 promoter was prepared by PCR using 32P-end-labeled primers. Two femtomoles of probe was used in 25-pA reaction mixtures containing 6 ,ug of nuclear extract and 8 ,ug of poly(dI-dC presence of pMV-src was 40-fold greater than in the presence of pEVX (data not shown).
The TIS10/PGS2 regulatory region has several consensus sequences for transcriptional activation, including two potential NF-IL6 response elements and an Spl consensus sequence ( Fig. 1) . Further 3', centered at 50 nucleotides from the transcription start site, are two overlapping consensus regulatory elements. The first sequence, the cyclic AMP (cAMP) response element or ATF/CRE, binds ATF/CREB transcription factors. The second sequence, the E box, binds basic helix-loop-helix transcription factors such as Myc, Max, Mad, and USF. We constructed additional TIS10/PGS2 promoter deletions fused to the luciferase reporter and cotransfected these constructs into NIH 3T3 cells along with either the pMV-src expression vector or the pEVX vector. For constructs between -371 and -80, the response to pMV-src cotransfection was in the range of 40-to 100-fold greater than that for cotransfection with pEVX. However, deletion to nucleotide -40 eliminates induction by pp60v-sc (Fig. 2) . We report both the enzymatic activities in luciferase units per constructs used in the following experiments are shown in Fig.  1 .
The sequence between nucleotides -65 and -39 of the TIS10/PGS2 gene interacts with DNA-binding proteins that recognize ATF/CRE sequences and E-box sequences. UPlAl is a BALB/c 3T3 cell line that has been stably transfected with a temperature-sensitive v-src gene (37) . When UPlAl cells are shifted to the permissive temperature, transcription from the endogenous TIS10/PGS2 gene is rapidly expressed. We used nuclear extracts from these cells to perform gel shift analyses. Nuclear extracts were prepared from UPlAl cells grown at the permissive and nonpermissive temperatures, and gel shift analyses were performed with radiolabeled probes extending from -82 to -62 and from -65 to -39 of the TIS10/PGS2
promoter. No retardation of the probe extending from -82 to -62 was observed with nuclear extracts from cells grown at either temperature (data not shown). We observed four retarded bands with nuclear extracts from UPlAl cells when the sequence from -65 to -39, containing the overlapping ATF/ CRE and E-box regions of the TIS10/PGS2 gene, was used as a probe (Fig. 3) . The presence of four bands is more clearly demonstrated by competition assays (described below). We saw no differences in the gel mobility patterns with extracts from cells grown at the permissive and nonpermissive temperatures and show only data obtained with extracts from the permissive temperature.
To identify which complexes are associated with the two putative DNA-binding sequences, we used unlabeled ATF/ CRE and E-box consensus sequences ( Fig. 1) The sequence GTCAC within the overlapping ATF/CRE and E box is conserved in the mouse, rat, and human PGS2 promoters. Using a 32-bp probe from the TIS10 promoter centered on GTCAC but mutated in the ATF/CRE and E-box sites, we performed a gel retardation analysis with UPlAl cell extract to determine whether another factor binds to the TIS10/PGS2 promoter by recognizing this sequence. We are unable to identify any novel factor which associates specifically with the conserved GTCAC TIS10/PGS2 promoter sequence.
The TIS1O/PGS2 ATF/CRE and E-box elements are recognized by DNA-binding proteins with these specificities in vivo.
To determine whether the -80 to -40 region of the TIS10/ PGS2 gene can interact in cells with proteins that bind to the ATF/CRE and E-box elements, we used dominant-negative transcription factor mutants that recognize either the ATF/ CRE or E-box sequence in cotransfection experiments. NIH 3T3 cells were transfected with (i) the pTIS1080 luciferase reporter containing the TIS10/PGS2 promoter sequence from -80 to +3, (ii) either the v-src expression vector or the corresponding empty vector, and (iii) increasing amounts of D106, an expression vector that encodes a Myc protein with an intact DNA-binding domain and an inactivated transactivation domain (49) . Empty D106 expression vector was used to keep the DNA concentration constant. D106 dominant-negative Myc protein, which binds to E-box sequences, blocks nearly completely v-src induction of pTIS10-80 (Fig. 4) . The In373 plasmid encodes a Myc protein that is unable to bind to E-box sequences but has an intact transactivation domain (56) . In373 Myc protein did not block v-src induction of pTIS10O80, indicating that E-box binding by the dominant-negative D106 protein is required to block TIS10/PGS2 induction.
The dominant-negative CREB protein Ml is altered at a phosphorylation site in the transcriptional activation domain and cannot be converted to an active transcription factor by protein kinase A phosphorylation (18) . However, the ATF/ CRE-binding domain of the Ml mutant is intact. Cotransfection with the plasmid expressing the Ml dominant-negative CREB protein also blocks v-src activation of pTIS10_80 (Fig.  4) . We conclude that binding, in cells, of nontransactivating proteins to either the ATF/CRE element or the E-box element of the TIS10/PGS2 gene can block v-src induction of transcription. TIS10/PGS2 promoter mutations demonstrate that the ATF/CRE element, but not the E box, is necessary for pp6O-src induction. It is possible that (i) binding of both an ATF/CREB transcription factor and an E-box transcription factor is necessary for TIS10/PGS2 induction by v-src, (ii) a protein(s) binding to only one or the other of these two elements is essential for induction of this gene, or (iii) no protein binding to this region is necessary for induction, but binding to this sequence interferes with induction. To distinguish among these possibilities we performed a mutational analysis.
Three luciferase reporter constructs were prepared. The WT (wild-type) construct maintains the nine-nucleotide ATF/CRE and E-box sequences and the surrounding TIS10/PGS2 sequences intact but incorporates the restriction sites used to make the other two constructs. In the E-box* construct, the last two bases of the TIS1O/PGS2 E box are mutated (Fig. 1) sponse to pp6ovsrc expression (Fig. 5) . Although the absolute level of pp60v"-induced luciferase activity for the E-box mutant is slightly reduced (about twofold) in comparison with the WT construct, the basal level of luciferase activity is also reduced. The fold induction of pp60v-src-induced luciferase activity for the E-box* mutant (147-fold) is actually increased over that observed with the WT construct (73-fold). In contrast, mutation of the TIS10/PGS2 ATF/CRE element extensively reduces induction by pp6Ovsrc. We conclude (i) that the TIS10/PGS2 E box is not required for regulation by pp6ov-src and (ii) that the ATF/CRE sequence CGTCA at nucleotides -56 to -52 is essential for pp60vsrc-mediated TIS10/PGS2 induction. A 27-nucleotide sequence identical to the TIS10/PGS2 promoter sequence between -64 to -38, placed in front of a minimal thymidine kinase promoter, was unable to confer pp6Ovsrc inducibility to a luciferase reporter gene (data not shown). These data suggest the ATF/CRE element is necessary but not sufficient for induction by pp6Ovsrc.
CREB and a second ATF family member bind to the TIS10/PGS2 ATF/CRE element. There exists an extensive family of proteins that recognize ATF/CRE sequences (6, 20) .
To more completely characterize the proteins that bind to the TIS10/PGS2 ATF/CRE element, we used antibody supershift experiments. Two distinct retarded complexes (complex 1 and complex 3) are formed between the TIS10/PGS2 ATF/CRE element and nuclear extracts from UPlAl cells (Fig. 3) . CREB is the best-characterized member of the ATF family (6) . Addition of anti-CREB antibody to the gel retardation reac-FIG. 6. The TIS10/PGS2 regulatory region forms complexes that contain CREB, a second member of the ATF family. (A) Nuclear extract, anti-CREB antibody (a gift from Marc Montminy), and the labeled 27-nucleotide probe from -65 to -39 of the TIS10/PGS2 regulatory region were incubated as described in Materials and Methods and then subjected to electrophoresis. In lanes 4 and 5, the E-box competitor ( Fig. 1 ) was included at a 40-fold molar excess. The ATF and E-box designations for retarded complexes are based on the competition data of Fig. 3 . The CREB and CREB/anti-CREB designations are based on the antibody supershift data shown here. (B) The TIS10/PGS2 probe was incubated either with nuclear extract or with recombinant CREB protein (the gift of Marc Montminy) prior to electrophoresis. tion prior to electrophoresis causes a supershift of complex 3, the more rapidly migrating of the two ATF/CRE complexes (Fig. 6A) . This supershift result is made particularly clear when the anti-CREB experiment is done in the presence of unlabeled E-box competitor, to eliminate complex 2 and complex 4 (Fig. 6B, lanes 4 and 5) . We conclude that complex 3 contains CREB and that complex 1 contains another ATF family member(s). To confirm this hypothesis, we compared the complexes formed with this region of the TIS10/PGS2 promoter by UPlAl nuclear extracts and by recombinant CREB protein (Fig. 6B) . Recombinant CREB protein forms a complex that migrates similarly to complex 3 formed with nuclear extracts.
Methylation interference experiments define the contact points of the proteins in complexes 1 and 3 with the TIS10/ PGS2 ATF/CRE region. To further characterize the ATF/CRE region of the TIS10/PGS2 gene, we determined which guanine residues, when methylated, interfere with gel retardation complex formation with UPlAl nuclear extracts and with recombinant CREB protein. TIS10/PGS2 probes labeled on either the upper or lower strand with 32P and subjected to limited methylation with dimethyl sulfate (see Materials and Methods) were incubated with UPlAl nuclear extracts or with recombinant CREB protein and subjected to electrophoresis. The incubations also contained unlabeled E-box competitor for complex 2 and complex 4. Retarded complexes and free probe were identified by autoradiography, excised, subjected to piperidine cleavage, and subjected to electrophoresis.
Recombinant CREB protein is unable to interact with the probe in which guanines at positions -53 and -56 on the lower strand of the TIS10/PGS2 promoter are methylated (Fig.  7) . These are the guanines in the lower strand of the consensus The proteins present in complexes 1 and 3 formed by 3T3 cell nuclear extracts and the TIS10/PGS2 promoter make contacts with the guanines of the upper and lower strands of the ATF/CRE region. 32P-labeled upper-and lower-strand probes were subjected to limited methylation with dimethyl sulfate, incubated with nuclear extracts from UPlAl cells or with recombinant CREB protein in the presence of excess E-box competitor, and subjected to electrophoresis in a nondenaturing gel. Retarded complexes 1 and 3 (the retarded CREB complex) and free probe (CONT) were identified by autoradiography and cut from the gel. DNA was isolated, subjected to piperidine cleavage, and analyzed on a sequencing gel. Labeled lower-strand probe was used for panel A; labeled upper strand probe was used for panel B. ATF/CRE element. Methylation of these guanines also interferes with formation of complex 1 (38, 54) . To investigate whether the ras gene product might mediate v-src induction of the TIS10/PGS2 gene, we again used a dominant-negative strategy. We cotransfected increasing amounts of pZIPM17, a plasmid expressing a dominant-negative H-Ras protein, into NIH 3T3 cells along with constant amounts of pTIS10_80 and either pMV-src or pEVX (Fig. 8) (51, 52) . Mutation of the C/EBP sequence reduces forskolin induction of a rat promoter-reporter construct by 50% (52) , suggesting that other regions of the rat PGS2 gene may also contribute to regulation by forskolin and pituitary hormones.
The ATF/CRE element is present in a number of viral and eukaryotic promoters (6, 64) . About 10 ATF/CREB family members have been cloned. Thus, the ATF/CRE sequence is a widely used regulatory element that confers complex transcriptional regulatory features on many genes. The transactivation, selectivity, and specificity of ATF/CREB transcription factors are achieved in many ways; they exhibit great functional diversity, through the formation of heterodimers and homodimers (6, 20, 32, 64) . ATF proteins are activated by several signal transduction pathways. CREB (18) , CREM (14) , and ATF-1 (45) (27) . Methylation interference experiments demonstrate that proteins present in nuclear extracts contact an extended region of the TIS10/PGS2 sequence compared with recombinant CREB. This may be due to an ATF protein that makes contact over a larger DNA sequence than does CREB. Alternatively, auxiliary factors may form complexes with ATF proteins at the TIS10/PGS2 ATF/CRE element, creating additional contact sites.
The 5'-CGTCACGTG-3' sequence in the TIS10/PGS2 gene may allow for increased regulatory complexity by the overlap of the ATF/CRE element and the E box. Our mutational data suggest that the TIS10/PGS2 E box is not involved in v-src induction. Antibodies to Myc do not supershift the complexes formed between the TIS10/PGS2 E box and UPlAl nuclear extracts (data not shown). However, the E box is a core element that is recognized by a wide range of basic helix-loophelix homodimeric and heterodimeric transcription factors. E-box elements and cell-type-specific basic helix-loop-helix dimers that modulate expression regulate the acetylcholine receptor (4), tyrosine hydroxylase (17, 63) , and calcitonin (40) genes. Cell-type-specific E-box-binding proteins may be involved in the modulation of TIS10/PGS2 expression in specific cell types, e.g., myoblasts or neurons. The E box might also serve as a site of cell-type-specific repression, preventing TIS10/PGS2 expression. An E-box-binding protein that can repress transcription has recently been described (34) . In this regard, it is interesting that differentiation-deficient murine myoblast cell lines are lacking MyoD (a basic helix-loop-helix protein that binds to the E box) and synthesize prostaglandin E2, while the parental myoblast cells express MyoD and do not produce prostaglandin (46) . Moreover, MyoD overexpression in differentiation-deficient myoblast cell lines suppresses prostaglandin E2 production (59) .
The TIS10/PGS2 gene can be activated by a variety of extracellular stimuli, including platelet-derived growth factor (PDGF), colony-stimulating factor, serum, endotoxin, and interleukins. pp60vsrc and other cellular Src family tyrosine kinases are thought to be involved in signal transduction pathways initiated by several of these ligands, including PDGF (30) , colony-stimulating factor (9) , and interleukin-2 (25) . Microinjection of kinase-deficient, dominant-negative mutants of Src and Fyn and microinjection of antibodies to Src, Fyn, or Yes demonstrate that the cellular Src family kinases play a required role in PDGF-stimulated DNA synthesis in NIH 3T3 cells (57) . It seems likely that pp60vs'c is also involved in the signal transduction pathways leading from at least some of these ligands to TIS10/PGS2 gene transcription. Dominantnegative CREB blocks serum and PDGF induction of the pTIS10s reporter construct (extending from nucleotide -371; data not shown). No serum response elements or Sis-inducible elements are present in the TIS10/PGS2 promoter region that confers responsiveness of luciferase constructs to these agents (13) . It seems likely, therefore, that the TIS10/PGS2 ATF/ CRE element also plays a role in the induction of transcription of this gene by several ligands.
